Home
/
Cannabis Bioscience International Holdings, Inc.
/
Financials
/
Quarterly
Cannabis Bioscience International Holdings, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Cannabis Bioscience International Holdings, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Feb 28, 2026
$11.2K
Apr 16, 2026
Q2
2026
Nov 30, 2025
$53.3K
Feb 19, 2026
Q1
2026
Aug 31, 2025
$24.2K
Oct 22, 2025
Q3
2026
Feb 28, 2025
$14.9K
Apr 16, 2026
Q2
2026
Nov 30, 2024
$74.2K
Feb 19, 2026
Q1
2026
Aug 31, 2024
$178.9K
Oct 22, 2025
Q3
2025
Feb 29, 2024
$36.4K
May 9, 2025
Q2
2024
Nov 30, 2023
$63.7K
Jan 25, 2024
Q1
2025
Aug 31, 2023
$72.8K
Oct 21, 2024
Q3
2024
Feb 28, 2023
$51.3K
Apr 22, 2024
Q2
2024
Nov 30, 2022
$82.6K
Jan 25, 2024
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2012
Feb 29, 2012
$8.57M
Apr 20, 2012
Q2
2012
Nov 30, 2011
$15.52M
Jan 23, 2012
Q1
2012
Aug 31, 2011
$17.29M
Nov 7, 2011
Q3
2012
Feb 28, 2011
$20.78M
Apr 20, 2012
Q2
2012
Nov 30, 2010
$25.93M
Jan 23, 2012
Q1
2012
Aug 31, 2010
$21.19M
Nov 7, 2011
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Feb 28, 2026
($103.9K)
Apr 16, 2026
Q3
2026
Nov 30, 2025
($117.0K)
Apr 16, 2026
Q2
2026
Nov 30, 2025
($117.0K)
Feb 19, 2026
Q2
2026
Aug 31, 2025
($82.6K)
Feb 19, 2026
Q1
2026
Aug 31, 2025
($82.6K)
Oct 22, 2025
Q3
2026
Aug 31, 2025
($82.6K)
Apr 16, 2026
Q3
2026
Feb 28, 2025
($181.2K)
Apr 16, 2026
Q3
2026
Nov 30, 2024
($79.5K)
Apr 16, 2026
Q2
2026
Nov 30, 2024
($79.5K)
Feb 19, 2026
Q1
2026
Aug 31, 2024
($76.3K)
Oct 22, 2025
Q3
2026
Aug 31, 2024
($76.3K)
Apr 16, 2026
Q2
2026
Aug 31, 2024
($76.3K)
Feb 19, 2026
Q3
2025
Feb 29, 2024
($209.2K)
May 9, 2025
Q3
2025
Nov 30, 2023
($124.4K)
May 9, 2025
Q2
2024
Nov 30, 2023
($124.4K)
Jan 25, 2024
Q1
2025
Aug 31, 2023
($181.8K)
Oct 21, 2024
Q2
2024
Aug 31, 2023
($181.8K)
Jan 25, 2024
Q3
2025
Aug 31, 2023
($181.8K)
May 9, 2025
Q3
2024
Feb 28, 2023
($324.7K)
Apr 22, 2024
Q2
2024
Nov 30, 2022
($219.9K)
Jan 25, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Feb 28, 2026
($93.3K)
Apr 16, 2026
Q2
2026
Nov 30, 2025
($95.9K)
Feb 19, 2026
Q1
2026
Aug 31, 2025
($74.8K)
Oct 22, 2025
Q3
2026
Feb 28, 2025
($129.2K)
Apr 16, 2026
Q2
2026
Nov 30, 2024
($59.6K)
Feb 19, 2026
Q1
2026
Aug 31, 2024
($97.6K)
Oct 22, 2025
Q3
2025
Feb 29, 2024
($160.0K)
May 9, 2025
Q2
2024
Nov 30, 2023
($94.5K)
Jan 25, 2024
Q1
2025
Aug 31, 2023
($176.8K)
Oct 21, 2024
Q3
2024
Feb 28, 2023
($284.9K)
Apr 22, 2024
Q2
2024
Nov 30, 2022
($183.6K)
Jan 25, 2024
Q3
2012
Feb 29, 2012
($1.02M)
Apr 20, 2012
Q2
2012
Nov 30, 2011
$2.84M
Jan 23, 2012
Q1
2012
Aug 31, 2011
$4.66M
Nov 7, 2011
Q3
2012
Feb 28, 2011
($1.56M)
Apr 20, 2012
Q2
2012
Nov 30, 2010
$5.38M
Jan 23, 2012
Q1
2012
Aug 31, 2010
$4.69M
Nov 7, 2011